减重内镜下胃窦肌切开术:一项评估技术可行性、生理变化和初步疗效的初步研究
这项单中心初步研究评估了采用黏膜下隧道技术的减重内镜下胃窦肌切开术(BEAM),6 例受试者均手术成功;6 个月和 12 个月总体重减轻分别为 9.1%±8.9% 和 12.2%±7.1%(P<.0005),胃排空率延迟 36.6%(体重减轻≥10% 者),12 个月胃轻瘫主要症状指数评分显著升高。
要点
- BEAM 技术可行,6 例均成功完成。
- 6 个月和 12 个月总体重减轻分别为 9.1%±8.9% 和 12.2%±7.1%(P<.0005)。
- 体重减轻≥10% 者胃排空率延迟 36.6%,12 个月胃轻瘫主要症状指数评分显著升高。
核心结论
- 这项初步研究提示 BEAM 可行,似乎可诱导胃排空延迟,并与显著体重减轻相关,且无胃轻瘫症状。
研究设计与样本
- 单中心初步研究,评估采用黏膜下隧道技术的减重内镜下胃窦肌切开术(BEAM),共 6 例受试者。
- 主要结局为 6 个月和 12 个月时的可行性、安全性和疗效,次要结局为胃排空率和胃轻瘫主要症状指数(GCSI)评分的变化。
主要发现
- 6 例受试者均成功完成 BEAM;1 例需要穿刺针减压,另 1 例发生肺栓塞,治疗后无后遗症。
- 6 个月和 12 个月总体重减轻分别为 9.1%±8.9% 和 12.2%±7.1%(P<.0005)。
- 体重减轻≥10% 者的胃排空率延迟 36.6%。
- 12 个月时 GCSI 评分显著升高,尤其是早饱方面。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Gastric balloons and endoscopic sleeve gastroplasty appear to work by delaying gastric emptying. We hypothesized that pylorus-sparing antral myotomy would inhibit the antral pump, inducing gastric retention and similarly resulting in weight loss. METHODS: In this single-center pilot study, we assessed bariatric endoscopic antral myotomy (BEAM) using submucosal tunneling. The primary outcomes were feasibility, safety, and efficacy at 6 and 12 months, whereas the secondary outcomes were changes in the gastric-emptying rate and gastroparesis cardinal symptom index (GCSI) score. RESULTS: Six subjects underwent successful BEAM. One required needle decompression, and another developed pulmonary embolism, treated without sequela. At 6 and 12 months, patients achieved 9.1% ± 8.9% and 12.2% ± 7.1% total weight loss (P < .0005). The gastric-emptying rate was delayed by 36.6% in those with ≥10% total weight loss. The GCSI score increased significantly at 12 months, particularly regarding early satiety. CONCLUSIONS: This pilot study suggests BEAM is feasible and appears to induce delayed gastric emptying that is associated with significant weight loss, without symptoms of gastroparesis.
引用
- Thompson CC, Jirapinyo P. Bariatric endoscopic antral myotomy: a pilot study assessing technical feasibility, physiologic changes, and preliminary efficacy. Gastrointest Endosc. 2024. PMID: 38729312. doi:10.1016/j.gie.2024.04.2925
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。